Tone mix
Week by week 52 weeks
Share of Nuvation Bio Inc.'s 144 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jan 19, 2026 · tone -50Nuvation Bio Inc. (NUVB) Price Target Lowered as IBTROZI Sales Meet Expectations-86
- Week of Oct 27, 2025 · tone 0Nuvation Bio to Participate in Upcoming Investor Conferences-74
- Week of Aug 25, 2025 · tone +100H.C. Wainwright Reiterates a Buy Rating on Nuvation Bio (NUVB)+70
- Week of Aug 31, 2026 · tone +99Cramer's lightning round: Nuvation Bio 'is a pure spec'+68
- Week of Sep 15, 2025 · tone +100Nuvation Bio Says Japan Approves IBTROZI For ROS1+ Advanced Non-small Cell Lung Cancer Treatment+64
- Week of Aug 17, 2026 · tone +100Nuvation Bio Secures FDA Fast Track For Safusidenib In IDH1- Mutant Glioma+64
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Nuvation Bio Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 5 | +20 |
| Last 30 sessions | 12 | +17 |
| Last 90 sessions | 34 | +26 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.fool.com · 1 outletNuvation Bio (NUVB) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nuvation Bio (NUVB) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletNuvation Bio (NYSE:NUVB) Announces Earnings ResultsNeutral
- www.prnewswire.com · 1 outletNuvation Bio Reports Third Quarter 2026 Financial Results and Provides Business UpdateNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nuvation Bio (NYSE:NUVB) Announces Earnings Results | www.themarketsdaily.com | 1 | Neutral |
| Nuvation Bio Reports Third Quarter 2026 Financial Results and Provides Business Update | www.prnewswire.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletHead to Head Contrast: Nuvation Bio (NYSE:NUVB) and Immunocore (NASDAQ:IMCR)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head to Head Contrast: Nuvation Bio (NYSE:NUVB) and Immunocore (NASDAQ:IMCR) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 30, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.rttnews.com · 1 outletNuvation Bio Advances Phase 3 Trial Of Safusidenib As Maintenance Therapy For GliomaPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nuvation Bio Advances Phase 3 Trial Of Safusidenib As Maintenance Therapy For Glioma | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletHead to Head Analysis: Immunocore (NASDAQ:IMCR) & Nuvation Bio (NYSE:NUVB)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head to Head Analysis: Immunocore (NASDAQ:IMCR) & Nuvation Bio (NYSE:NUVB) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Nuvation Bio Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.